Zobrazeno 1 - 6
of 6
pro vyhledávání: '"KyungMin Yoo"'
Autor:
Erin Maloney, Casey Clark, Hemamylammal Sivakumar, KyungMin Yoo, Julio Aleman, Shiny A. P. Rajan, Steven Forsythe, Andrea Mazzocchi, Adrian W. Laxton, Stephen B. Tatter, Roy E. Strowd, Konstantinos I. Votanopoulos, Aleksander Skardal
Publikováno v:
Micromachines, Vol 11, Iss 2, p 208 (2020)
The current drug development pipeline takes approximately fifteen years and $2.6 billion to get a new drug to market. Typically, drugs are tested on two-dimensional (2D) cell cultures and animal models to estimate their efficacy before reaching human
Externí odkaz:
https://doaj.org/article/e560ef6435b14d3a8a10eb2838db31ea
Autor:
Kyungmin Yoo, Na Young Kim
Publikováno v:
The Korean Journal of Local Government Studies. 24:101-123
Autor:
Jin Gyo Jeong, DongHyun Kim, Young Jae Kim, Kyungmin Yoo, Kyungeun Ha, Wook-Jin Chung, Kwang Gi Kim
Cardiovascular disease is the leading cause of death worldwide. A key factor in assessing the risk of cardiovascular disease is left ventricular functional evaluation. Left ventricular (LV) systolic function is evaluated by measuring the left ventric
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::400da0f136ede829f7d417794bfb240d
https://doi.org/10.20944/preprints202203.0140.v1
https://doi.org/10.20944/preprints202203.0140.v1
Autor:
KyungMin Yoo, Richard Connor Huntwork, Mark E. Welker, Hemamylammal Sivakumar, Casey Clark, Shay Soker, Kalan Leaks, Paul Gatenholm, Surya R. Banks, Tracy Criswell, Emmanuel C. Opara, Julio Aleman, Aleksander Skardal, Alexandra Maycock, Samuel Herberg, Kevin Enck, Thomas DePalma, Yu Zhou, Andrea Mazzocchi
The field of three-dimensional (3D) bioprinting has advanced rapidly in recent years. Significant reduction in the costs associated with obtaining functional 3D bioprinting hardware platforms is both a cause and a result of these advances. As such, t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::28180aff9bdb0a990eb223560dc51851
https://doi.org/10.1101/2021.09.01.458584
https://doi.org/10.1101/2021.09.01.458584
Autor:
Julio Aleman, Casey Clark, Hemamylammal Sivakumar, KyungMin Yoo, Roy E. Strowd, Adrian W. Laxton, Erin Maloney, Stephen B. Tatter, Konstantinos I. Votanopoulos, Andrea Mazzocchi, Steven Forsythe, Shiny Amala Priya Rajan, Aleksander Skardal
Publikováno v:
Micromachines
Micromachines, Vol 11, Iss 2, p 208 (2020)
Volume 11
Issue 2
Micromachines, Vol 11, Iss 2, p 208 (2020)
Volume 11
Issue 2
The current drug development pipeline takes approximately fifteen years and $2.6 billion to get a new drug to market. Typically, drugs are tested on two-dimensional (2D) cell cultures and animal models to estimate their efficacy before reaching human
Publikováno v:
Journal of Korean Society of Environmental Engineers. 38:343-352